Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00261911
Status:
COMPLETED
Last Update Posted:
2007-08-31
First Post:
2005-12-02
Brief Title:
A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
A 12 Month Study to Assess Safety and Efficacy of Meridia Sibutramine Hydrochloride Monohydrate 10 and 15 mg in Obese Adolescents
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the effectiveness of sibutramine on weight loss reduction in body size and improvement in metabolic risk factors and safety in obese adolescents
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None